Geneart Overview

  • Founded
  • 1999
  • Status
  • Private
  • Employees
  • 185
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $41.3M
Latest Deal Amount

Geneart General Information


Manufacturer of integrated system solutions for DNA engineering and processing. The company provides software and a robotics platform enabling DNA synthesis for the fermentation of recombinant proteins, combinatorial biology and vaccines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • BioPark Josef-Engert-Strasse 11
  • 93053 Regensburg
  • Germany
+49 0941 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 08-Apr-2010 $41.3M 000.00 000.00 Completed Generating Revenue
3. IPO 23-May-2006 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 20-Sep-2002 $3.92M $3.92M Completed Product Development
1. Early Stage VC 01-May-2000 Completed Product Development
To view Geneart’s complete valuation and funding history, request access »

Geneart Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial